Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

High-Intensity Laser Therapy in Hemiplegic Shoulder Pain

NCT: NCT07501416 · NOT_YET_RECRUITING

NCT IDNCT07501416
StatusNOT_YET_RECRUITING
Start Date2026-04-01
Completion2027-01-30

Brief Summary

This randomized, sham-controlled clinical trial aims to evaluate the effectiveness of high-intensity laser therapy (HILT) combined with exercise on pain, functional status, disability, and ultrasonographic findings in patients with hemiplegic shoulder pain following stroke.

Frequently Asked Questions

What is High-Intensity Laser Therapy in Hemiplegic Shoulder Pain?

High-Intensity Laser Therapy in Hemiplegic Shoulder Pain is a clinical trial registered under NCT07501416. Current status: NOT_YET_RECRUITING.

What is the status of NCT07501416?

The current status of NCT07501416 (High-Intensity Laser Therapy in Hemiplegic Shoulder Pain) is: NOT_YET_RECRUITING.

When did High-Intensity Laser Therapy in Hemiplegic Shoulder Pain start?

High-Intensity Laser Therapy in Hemiplegic Shoulder Pain started on 2026-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.